Scarica l'app Stockscreener
17.96
1.10%
-0.20
Pre-mercato:
17.92
-0.04
-0.22%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché KVUE Giù?
Forum
Previsione
Storia dei dividendi
Kenvue Inc Borsa (KVUE) Ultime notizie
How Is Kenvue’s Stock Performance Compared to Other Consumer Staple Stocks? - Barchart.com
UBS Raises Kenvue Inc. (KVUE) Price Target to $19 After Strong Q4 Results - Finviz
My Top 3 Dividend Kings to Buy for March 2026 - The Motley Fool
Van ECK Associates Corp Buys 9,240,434 Shares of Kenvue Inc. $KVUE - MarketBeat
Richard Bernstein Advisors LLC Lowers Stock Position in Kenvue Inc. $KVUE - MarketBeat
Aveeno® announces research collaboration to advance skin health science and educationA new view of care - Kenvue
WINTON GROUP Ltd Takes Position in Kenvue Inc. $KVUE - MarketBeat
Korea Investment CORP Acquires 1,470,295 Shares of Kenvue Inc. $KVUE - MarketBeat
CI Investments Inc. Sells 519,412 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. $KVUE Position Reduced by Victory Capital Management Inc. - MarketBeat
Neuberger Berman Group LLC Grows Stake in Kenvue Inc. $KVUE - MarketBeat
Kimberly-Clark Kenvue Deal And New Tech Leader Reshape Growth Story - Yahoo Finance
Athos Capital Ltd Purchases Shares of 2,500,000 Kenvue Inc. $KVUE - MarketBeat
Analysts Have Conflicting Sentiments on These Consumer Goods Companies: Kenvue, Inc. (KVUE) and Sysco (SYY) - The Globe and Mail
Is Kenvue (KVUE) Pricing Reflect Its Post Johnson & Johnson Spin Off Prospects - Yahoo Finance
Kenvue (KVUE): Barclays Adjusts Price Target to USD 19.00 | KVUE Stock News - GuruFocus
Tylenol use in pregnancy fell after Trump’s autism warning: study - Seeking Alpha
Tylenol use among women dropped after Trump tied it to autism, Lancet analysis shows - marketscreener.com
Kenvue (NYSE:KVUE) Given New $19.00 Price Target at Barclays - MarketBeat
Kenvue price target raised to $19 from $18 at Barclays - TipRanks
Kenvue Inc. $KVUE Stock Position Increased by Dimensional Fund Advisors LP - MarketBeat
Kenvue: Out Of Favor Then, Under Pressure Now (KVUE) - Seeking Alpha
Barclays raises Kenvue stock price target on category growth - Investing.com
Barclays raises Kenvue stock price target on category growth By Investing.com - Investing.com Nigeria
Burgundy Asset Management Ltd. Trims Holdings in Kenvue Inc. $KVUE - MarketBeat
Kenvue (NYSE: KVUE) grants CTO 79,407 RSUs vesting 2027-2029 - Stock Titan
Kenvue (NYSE: KVUE) grants 63,525 RSUs to Chief Scientific Officer - Stock Titan
Kenvue (KVUE) Valuation Revisited After Schafer Cullen Exit And Ongoing Consumer Headwinds - simplywall.st
US Bancorp DE Has $2.41 Million Stock Position in Kenvue Inc. $KVUE - MarketBeat
Skba Capital Management LLC Has $13.73 Million Holdings in Kenvue Inc. $KVUE - MarketBeat
Elo Mutual Pension Insurance Co Has $4.44 Million Position in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. stock falls Tuesday, underperforms market - MarketWatch
Kenvue Inc (KVUE) Trading Down 3.2% on Mar 3 - GuruFocus
Zyrtec® joins PGA TOUR as the first official allergy relief sponsor - Kenvue
Kenvue Inc. $KVUE Shares Sold by Bahl & Gaynor Inc. - MarketBeat
APG Asset Management N.V. Has $18.23 Million Holdings in Kenvue Inc. $KVUE - MarketBeat
Kenvue Shares Tumble 27.9% Below 52-Week High as Earnings Misses and Strategic Uncertainty Send Stock to 229th in Daily Trading Activity - Bitget
Will Strong Q4 Results and Schafer Cullen’s Exit Change Kenvue’s (KVUE) Investment Narrative? - simplywall.st
Kimberly-Clark Seeks Clearance To Acquire Kenvue - supermarketnews.co.nz
Kimberly-Clark seeks New Zealand clearance for Kenvue acquisition - MLex
Kenvue Inc. stock falls Monday, underperforms market - MarketWatch
Neutrogena agrees to $4.7M class action settlement over Skin360 biometric data - Class Action Lawsuits
Here’s Why SCCM Enhanced Equity Portfolio Exited Its Position in Kenvue (KVUE) - Insider Monkey
TD Asset Management Inc Sells 1,931,369 Shares of Kenvue Inc. $KVUE - MarketBeat
KVUE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Discipline and Rules-Based Execution in KVUE Response - Stock Traders Daily
Kenvue Inc. (KVUE): A Bull Case Theory - Finviz
Mitsubishi UFJ Asset Management Co. Ltd. Has $71.93 Million Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
American Century Companies Inc. Raises Stock Position in Kenvue Inc. $KVUE - MarketBeat
Westpac Banking Corp Sells 192,981 Shares of Kenvue Inc. $KVUE - MarketBeat
Judge rejects Kenvue bid to dismiss Texas lawsuit over Tylenol safety - WHTC
Kenvue Inc. stock rises Thursday, outperforms market - MarketWatch
Tylenol maker announces layoffs ahead of Kimberly-Clark buyout - The Business Journals
Kenvue Bid to Dismiss Texas AG Lawsuit Rejected by Judge - marketscreener.com
Kenvue Bid to Dismiss Texas AG Lawsuit Rejected by Judge, Reuters Reports - marketscreener.com
Kenvue effort to dismiss Tylenol case rejected by Texas judge (KVUE:NYSE) - Seeking Alpha
Judge rejects Kenvue bid to dismiss Texas lawsuit over Tylenol's safety - Yahoo
Judge rejects Kenvue bid to dismiss Texas Attorney General's lawsuit over marketing of Tylenol, court order shows - marketscreener.com
U.S. District Court for the District of New Jersey Judge Trims Benzene Class Claims Against Johnson & Johnson Consumer Inc. and Kenvue Inc. - USA Herald
NJ Judge Trims J&J and Neutrogena Benzene Suit - Law360
Kenvue Inc. stock falls Wednesday, underperforms market - MarketWatch
Kimberly-Clark Kenvue Deal Reshapes Growth Story And Investor Trade Offs - Yahoo Finance
Kenvue Agrees To $4.7 Million Skin360 Settlement - Happi | Household And Personal Products Industry
Assessing Kenvue (KVUE) Valuation As Recent Share Price Momentum Meets Mixed Longer Term Returns - simplywall.st
RBC Capital Reaffirms Their Hold Rating on Kenvue, Inc. (KVUE) - The Globe and Mail
Kenvue, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Metrics - Markets Mojo
1.77%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):